Comparative efficacy of saxagliptin combination therapy with acarbose, or gliclazide modified release, or metformin in drug naive patients with type 2 diabetes

被引：0
|
作者：
Chen, X. P. [1 ]
Li, H. M. [2 ]
Kuang, H. Y. [3 ]
Chen, L. [4 ]
Ma, J. H. [5 ]
Zhang, Q. [6 ]
Pan, T. R. [7 ]
He, J. [8 ]
Yang, W. Y. [1 ]
机构：
[1] China Japan Friendship Hosp, Beijing, Peoples R China
[2] China Meitan Gen Hosp, Beijing, Peoples R China
[3] Harbin Med Univ, Affiliated Hosp 1, Harbin, Heilongjiang, Peoples R China
[4] Shandong Univ, Qilu Hosp, Jinan, Shandong, Peoples R China
[5] Nanjing Med Univ, Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China
[6] Anhui Med Univ, Affiliated Hosp 1, Hefei, Anhui, Peoples R China
[7] Anhui Med Univ, Hosp 2, Hefei, Anhui, Peoples R China
[8] Tulane Univ, New Orleans, LA 70118 USA
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
768
引用
收藏
页码：S377 / S377
页数：1
相关论文
共 50 条
  • [41] Combination therapy with pioglitazone and metformin in patients with type 2 diabetes
    Egan, J
    Rubin, C
    Mathisen, A
    DIABETES, 1999, 48 : A117 - A117
  • [42] Clinical utility in the treatment of type 2 diabetes with the saxagliptin/metformin fixed combination
    Panagoulias, George S.
    Doupis, John
    PATIENT PREFERENCE AND ADHERENCE, 2014, 8 : 227 - 236
  • [43] Metformin/saxagliptin combination therapy can replace insulin therapy in patients with type 2 diabetes: interim results from the SAXAswitch study
    Pfuetzner, A. H.
    Schorsch, A.
    Forst, T.
    Pfuetzner, A.
    DIABETOLOGIA, 2011, 54 : S338 - S338
  • [44] Efficacy and Safety of Saxagliptin Added to Insulin With or Without Metformin in Chinese Patients with Type 2 Diabetes
    Chen, Yingli
    Liu, Xiaomin
    Li, Quanmin
    Ma, Jianhua
    Lv, Xiaofeng
    Guo, Lixin
    Wang, Changjiang
    Shi, Yongquan
    Li, Yanbing
    Johnsson, Eva
    Wang, Mei
    Zhao, June
    Ji, Linong
    DIABETES, 2017, 66 : A329 - A329
  • [45] A randomized controlled trial of the efficacy and safety of twice-daily saxagliptin plus metformin combination therapy in patients with type 2 diabetes and inadequate glycemic control on metformin monotherapy
    White, Judith L.
    Buchanan, Patricia
    Li, Jia
    Frederich, Robert
    BMC ENDOCRINE DISORDERS, 2014, 14
  • [46] A randomized controlled trial of the efficacy and safety of twice-daily saxagliptin plus metformin combination therapy in patients with type 2 diabetes and inadequate glycemic control on metformin monotherapy
    Judith L White
    Patricia Buchanan
    Jia Li
    Robert Frederich
    BMC Endocrine Disorders, 14
  • [47] Efficacy, effectiveness and safety of sulphonylurea-metformin combination therapy in patients with type 2 diabetes
    Hermann, LS
    Lindberg, G
    Lindblad, U
    Melander, A
    DIABETES OBESITY & METABOLISM, 2002, 4 (05): : 296 - 304
  • [48] Combination therapy with saxagliptin and dapagliflozin for the treatment of type 2 diabetes
    Williams, David M.
    Stephens, Jeffrey W.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (15) : 2373 - 2379
  • [49] Comparison of metformin, gliclazide MR and rosiglitazone in monotherapy and in combination for type 2 diabetes
    Vilar, Lucio
    Canadas, Viviane
    Arruda, Maria Juliana
    Arahata, Carla
    Agra, Rodrigo
    Pontes, Lisete
    Montenegro, Larissa
    Vilar, Clarice Freitas
    Moura e Silva, Lidiane
    Albuquerque, Jose Luciano
    Gusmao, Amaro
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2010, 54 (03) : 311 - 318
  • [50] Initial Combination Therapy With Alogliptin and Pioglitazone in Drug-Naive Patients With Type 2 Diabetes
    Rosenstock, Julio
    Inzucchi, Silvio E.
    Seufert, Jochen
    Fleck, Penny R.
    Wilson, Craig A.
    Mekki, Qais
    DIABETES CARE, 2010, 33 (11) : 2406 - 2408
12345